References
- HallTAMcGwinGJrSearceyKXieAHuppSLKlineLBHealth-related quality of life and psychosocial characteristics of patients with benign essential blepharospasmArch Ophthalmol2006124111611916401794
- HallettMEvingerCJankovicJStacyMUpdate on blepharospasm: Report from the BEBRF International WorkshopNeurology200871161275128218852443
- HallettMBlepharospasm: Recent advancesNeurology20025991306131212434791
- LeeYYehWCChongMYLinPYChangYYVenlafaxine and tar-dive blepharospasm: A case reportProg Neuropsychopharmacol Biol Psychiatry20073151139114017478026
- WakakuraMTsubouchiTInouyeJEtizolam and benzodiazepine induced blepharospasmJ Neurol Neurosurg Psychiatry200475350650714966178
- JankovicJOrmanJBotulinum A toxin for cranial cervical dystonia: A double-blind, placebo-controlled studyNeurology19873746166233561773
- Soares-WeiserKRathboneJNeuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesiaCochrane Database Syst Rev20061CD00045916437425
- WakakuraMNascent psychosomatic medicine in ophthalmologyJpn J Psychosom Med20105013742
- MaurielloJAJrCarbonaroPDhillonSLeoneTFranklinMDrug-associated facial dyskinesias. A study of 238 patientsJ Neuroophthalmology1998182153157
- JankovicJTardive syndromes and other drug-induced movement disordersClin Neuropharmacol1995183197148635179
- SachdevPTardive blepharospasmMov Disord19981369479519827620
- HorieCSuzukiYKiyosawaMDecreased dopamine D receptor binding in essential blepharospasmActa Neurol Scand20091191495418540899